Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexrazoxane + Mitoxantrone in Multiple Sclerosis
NCT01627938Phase 2Unknown
- Start
- Apr 2012
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dexrazoxane in multiple sclerosis (MS). Status: unknown.
02
Drugs
dexrazoxane
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01627938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01627938.